To the Editor: Sodium/glucose cotransporter 2 (SGLT2) inhibitors (SGLT2-Is) are increasingly used for glycemic control, cardiovascular and renal protection, and weight loss in type 2 diabetes mellitus (DM) (1). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.